Medifast (MED) Operating Expenses (2010 - 2026)

Medifast's Operating Expenses history runs 17 years deep, the most recent figure standing at $55.1 million for Q1 2026.

• Quarterly Operating Expenses fell 35.62% year-over-year to $55.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $258.9 million (down 36.52% YoY) and the FY2025 annual result came in at $289.4 million, down 34.49% from the prior year.
• Operating Expenses was $55.1 million for Q1 2026 at Medifast, down from $59.9 million in the prior quarter.
• Across five years, Operating Expenses topped out at $272.7 million in Q2 2022 and bottomed at $55.1 million in Q1 2026.
• A 5-year average of $140.7 million and a median of $131.3 million in 2024 frame the typical range for Operating Expenses.
• Annual changes were most pronounced in 2022 — Operating Expenses rose 26.28% — and 2025, when it slumped 40.82%.
• Medifast's Operating Expenses stood at $201.0 million in 2022, then sank by 33.98% to $132.7 million in 2023, then tumbled by 34.05% to $87.5 million in 2024, then tumbled by 31.5% to $59.9 million in 2025, then retreated by 8.16% to $55.1 million in 2026.
• Business Quant data shows MED's Operating Expenses at $55.1 million in Q1 2026, $59.9 million in Q4 2025, and $66.2 million in Q3 2025.